Is Sporlac DS good for your health

Probiotic

  1. Adami A, Cavazzoni V. Occurrence of selected bacterial groups in the faeces of piglets fed with Bacillus coagulans as probiotic. J Basic Microbiol 1999; 39: 3-9.
  2. Baron M. Apatented strain of Bacillus coagulans increased immune response to viral challenge. Postgrad Med 2009; 121: 114-118.
  3. Bergey D. Bergey's Manual of Determinative Bacteriology. 9th ed. Baltimore, MD: The Williams and Wilkens Company; 1993.
  4. Chandra RK. Effect of Lactobacillus on the incidence and severity of acute rotavirus diarrhea in infants. A prospective, placebo-controlled double-blind study. Nutr Res 2002; 22: 65-69.
  5. Czaczyk K, Trojanowska K, Mueller A. Antifungal activity of Bacillus coagulans against Fusarium sp. Acta Microbiol Pol 2002; 51: 275-283.
  6. Dolin BJ. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominantly irritable bowel syndrome. Methods Find Exp Clin Pharmacol 2009; 31: 655-659. Hun L. Bacillus coagulans significantly improved abdominal pain and bloating
  7. Dutta P, Mitra U, Dutta S, et al. Randomized controlled clinical trial of Lactobacillus sporogenes (Bacillus coagulans), used as a probiotic in clinical practice, on acute watery diarrhea in children. Trop Med Int Health 2011; 16: 555-561.
  8. Endres JR, Clewell A, Jade KA, et al. Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol 2009; 47: 1231-1238.
  9. Gilliland SE. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol Rev 1990; 7: 175-188.
  10. Hyronimus B, Le Marrec C, Urdaci MC. Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4. J Appl Microbiol 1998; 85: 42-50.
  11. in patients with IBS. Postgrad Med 2009; 121: 119-124.
  12. Jindal G, Pandey RK, Agarwal J, Singh M. A comparative evaluation of probiotics on salivary mutans streptococcicounts in Indian children. Eur Arch Pediatr Dent 2011; 12: 211-215.
  13. Johnston BC, Supina AL, Ospina M, Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2007; (2): CD004827.
  14. Joint FAO / WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada; April 30 and May 1, 2002.
  15. Kalman DS, Schwartz HI, Alvarez P, et al. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterol 2009; 9:85.
  16. Kodali VP, Sen R. Antioxidant and free radical scavenging activities of an exopolysaccharide from a probiotic bacterium. Biotechnol J 2008; 3: 245-251.
  17. Kumar ORM, Christopher KJ. Feeding of L. sporogenes to rabbits. Indian Vet J 1989; 66: 896-898.
  18. La Rosa M, Bottaro G, Gulino N, et al. Prevention of antibiotic-associated diarrhea with Lactobacillus sporogenes and fructo-oligosaccharides in children. A multicentric double-blind vs placebo study. Minerva Pediatr 2003; 55: 447-452. [Article in Italian]
  19. Majeed M, Prakash L. Lactospore O: The Effective Probiotic. Piscataway, NJ: NutriScience Publishers, Inc .; 1998.
  20. Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med 2010; 10: 1.
  21. Mathur SN, et al. Sporlac therapy in treatment of aphthous stomatitis. Uttar Pradesh State Dent J 1970; 11: 7-12. Cited in: Majeed M, Prakash L. Lactospore®: The Effective Probiotic. Piscataway, NJ: NutriScience Publishers, Inc .; 1998.
  22. Mohan JC, Arora R, Khalilullah M. Preliminary observations on the effect of Lactobacillus sporogenes on serum lipid levels in hypercholesterolemic patients. Indian J Med Res 1990; 92: 431-432.
  23. Riazi S, Wirawan RE, Badmaev V, Chikindas ML. Characterization of lactosporin, a novel antimicrobial protein produced by Bacillus coagulans ATCC 7050. J Appl Microbiol 2009; 106: 1370-1377.
  24. Sari FN, Dizdar EA, Oguz S, et al. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr 2011; 65: 434-439.
  25. Sharma JK, Kapoor KK, Mukhija RD. Clinical trial of Sporlac in the treatment of recurrent aphthous ulceration. Uttar Pradesh State Dent J 1980; 11: 7-12.
  26. Shirodkar NV, Sankholkar PC, Ghosh S, Nulkar SM. Multi-center clinical assessment of Myconip vaginal tablets in non-specific vaginitis. Indian Pract 1980; 33: 207-210.
  27. Smirnov VV, Reznik SR, V’iunitskaia VA, et al. The effect of the complex probiotic Sporolact on the intestinal microbiocenosis of warm-blooded animals. Mikrobiol Z 1995; 57: 42-49. [Article in Russian]